PRINTED PUBLICATIONS
1. F.Naccarella, B.Mantovani, C.Lamberti, S.Boschi, D.Bracchetti, B.Magnani
Analisi computerizzata dell'efficacia clinica della disopiramide e della procainamide e.v. in pazienti con extrasistolia ventricolare stabilizzata e complicata.
Boll.Soc.It.Card.24(12),1297,1979
2. E.Ambrosioni, C.Magelli, S.Boschi, L.Pasetti, B.Magnani
Clinical efficacy of gitoformate.
Drug.Exptl.Clin.Res. 6(3),221,1980
3. S.Boschi,B.Marchesini, L.Bassein, E.Strocchi
Bioavailability of a new formulation of the association sulphamethoxazole-trimethoprim.
Int.J.Clin.Pharm.Res. 1(3),175,1981
4. S.Boschi, B.Marchesini
High performance liquid chromatographic method for the simultaneous determination of iothalamate and o- iodohippurate.
J.Chromatogr.224,139,1981
5. P.L.Malini, F.Sarti, P.R.Dal Monte, A.Grepioni, S.Boschi, E.Ambrosioni
Effect of chronic liver disease on plasma levels and metabolism of digoxin and beta-methyldigoxin.
Int.J.Clin.Pharm.Res. 2(1),21,1982
6. B.Marchesini, S.Boschi, M.B.Mantovani
Determination of propafenone in serum or plasma by electron-capture gas-chromatography.
J.Chromatogr. 232,435,1982
7. G.Bandini, P.Ricci, G.Visani, S.Tura, S.Boschi
Measuring cyclosporin in plasma.
Lancet, 76, Apr26,1983
8. T.Busi, M.P.Rainaldi, C.Melloni, S.Boschi , A.Pirazzoli
Fazadinio bromuro. Note preliminari di farmacocinetica clinica.
Minerva Anestesiol. 49(9),485,1983
9. B.Marchesini, S.Boschi, C.Berti
Identification of a metabolite of propafenone in human urine by means of high performance liquid chromatography and gas chromatography mass spectrometry.
J.Chromatogr. 278,173,1983
10. E.Strocchi, P.L.Malini, S.Boschi , L.Bassein, E.Ambrosioni
Comparison of two methods for the evaluation of renal perfusion.
Meth.Find.Exptl.Clin.Pharmacol. 5(10),663,1983
11. M.P.Rainaldi, T.Busi, C.Melloni, S.Boschi
Pharmacokinetics and placental transmission of fazadinium bromide in elective ceasarian section.
Acta Anaesthesiol. Scand. 28,222,1984
12. S.Boschi, M.G.Di Marco, A.Pigna, R.Rossi
The effect of ranitidine on gastric pH and volume in patients undergoing caesarian section: possible relationship to Mendelson Syndrome.
Curr.Ther.Res. 35(4),654,1984
13. F.V.Costa, C.Borghi, S.Boschi , E.Ambrosioni
Cardiovascular response to mental stress: dynamic and isometric exercise in hypertensive patients treated with prizidilol hydrochloride (SKF92657).
Int.J.Clin.Pharm.Res. 4(5), 373,1984
14. G.Bandini, P.Ricci, G.Rosti, S.Rizzi, D.Malin, G.Visani, M.R.Motta, P.Franchi, D.Belletti, A.Zaccaria, S.Boschi, S.Tura
Cyclosporin A (Cy-A) prophylaxis of graft versus host disease (GVHD) in allogenic bone marrow transplantation (BMT).
Experimental Hematology 12(S5),74,1984
15. F.V.Costa, C.Borghi, S.Boschi , E.Ambrosioni
Different dosages of captopril and hydrochlorothiazide in the treatment of hypertension: long term effects on metabolic values and intracellular electrolytes.
J.Cardiovasc.Pharmacol. 7,S70,1985
16. E.Ambrosioni, F.V.Costa, C.Borghi, S.Boschi
Intralymphocytic potassium content and blood pressure. Their relationship at rest and during isometric exercise.
Klin. Wochenschr.,3,S3,9,1985
17. M.Campieri,G.A.Lanfranchi, S.Boschi , C.Brignola, G.Bazzocchi, P.Gionchetti, M.R. Minguzzi, A.Belluzzi, G.Labò
Topical administration of 5-Aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.
Gut 26(4),400,1985
18. S.Boschi, C.Borghi,F.V.Costa,E.Ambrosioni
Plasma Na/K ATPase inhibitory activity in normal and hypertensive subjects: relationships to intracellular electrolytes and blood pressure.
Clin.Exp.Hypertension A7(5&6),735,1985
19. G.Grossi, C.Sturani, R.Battistoni, A.Lippi, S.Boschi , E.Strocchi
Pharmacokinetics of mepixanox after oral and intravenous administration.
Curr.Ther.Res. 38(1),141,1985
20. E.Ambrosioni,F.V.Costa,C.Borghi,A.Mussi, S.Boschi
Modification of intra and extracellular sodium and potassium. A possible mechanism for the antihypertensive action of captopril and hydrochlorothyazide.
J.Hypertension,3(3),S69,1985
21. C.Borghi,F.V.Costa, A.Mussi, S.Boschi, E.Ambrosioni, B.Magnani
Modificazioni del rapporto intra/extracellulare di K prodotte dall'associazione captopril+idroclorotiazide in ipertesi normo e ipokaliemici.
Cardiologia,30,11(s),41,1985
22. A.Capucci, S.Gubelli, L.Visani, L.Frabetti, B.Marchesini, S.Boschi, E.Ambrosioni, B.Magnani
Tocainide plus metoprolol as a treatment of premature ventricular beats:a double-blind cross-over study.
New Trends in Arrhythmias, 2(1),301,1986
23. M.Campieri,G.A.Lanfranchi,C.Brignola, G.Bazzocchi, P.Gionchetti, M.R. Minguzzi, I.P. Capello, C.Corbelli, S.Boschi
Retrograde spread of 5-Aminosalicylic acid enemas in patients with ulcerative colitis.
Dis.Col.&Rect.,29(2),108,1986
24. E.Ambrosioni,F.V.Costa,C.Borghi, S.Boschi, A.Mussi
Cellular and humoral factors in borderline hypertension.
J.Cardiovasc.Pharmacol.,8(S5),S15,1986
25. C.Borghi,F.V.Costa, S.Boschi, A.Mussi, E.Ambrosioni
Predictors of stable hypertension in young borderline subjects: a five year follow-up study.
J.Cardiovasc.Pharmacol.,8(S5),S138,1986
26. E.Ambrosioni, C.Borghi, S.Boschi, F.V.Costa, A.Mussi
Intracellular Na/K content and post exercise vasodilatation in young normotensives with and without family hystory of hypertension.
Blood Vessels,23(2),56,1986
27. E.Ambrosioni, C.Borghi, S.Boschi, F.V.Costa
Antihypertensive effectiveness of diuretics is related to their effects on sodium,potassium and aldosterone.
J.Hypertension,4(S5),1986
28. S.Boschi ,A.Mussi
Dosaggio HPLC di betametildigossina, digossina e loro metaboliti deglicosilati nelle urine.
Biochim.Clin. ,1228,1986
29. S.Boschi, E.Strocchi, A.Mussi
Dosaggio di iotalamato e o-iodoippurato nello studio dell'emodinamica renale.
Biochim.Clin.,10,1231,1986
30. F.Marchetta, G.Bertacchini, L.Borgatti, A.L.Fantuzzi, L.Bassein, A.L.Calanchi, S.Boschi, F.V.Costa, E.Ambrosioni
Dietary patterns in samples of Bologna high school students with high and low blood pressure.
in:"Atherosclerosis and Cardiovascular disease",S.Lenzi & G.C.Descovich Eds., Vol.3,pag. 739,1987
31. G.Bandini, E.Strocchi, P.Ricci, S.Rizzi, S.Boschi, C.Guardigli, E.Calori, M.R.Motta, V.Giudice, G.Rosti, S.Tura
Cyclosporin A: Correlation of blood levels with acute graft- versus-host disease after bone marrow transplantation.
Acta Haematologica,78,6-12,1987
32. E.Ambrosioni, C.Borghi, S.Boschi, F.V.Costa, A.Mussi
The antihypertensive mechanism of diuretics.
in "Diuretics: Basic, Pharmacological and Clinical Aspects" V.E.Andreucci & A.Dal Canton Eds.,Martinus Nijhoff Publishing 1987,pag 225
33. C.Orlandi, M.G.Marlettini, A.Cassani, S.Boschi, S.Crippa, A.M.Morselli Labate, A.Contarini
Le atriopeptine in gravidanza.
in "Gestosi '87", I.Stoppelli editor,CIC Edizioni Internazionali, 1987 pag. 65
34. M.G.Marlettini, C.Borghi, S.Boschi, A.Cassani, S.Crippa, F.V.Costa
Renal sodium handling and an endogenous sodium pump inhibitor in pregnancy induced hypertension.
New Trends in Gynecology and Obstetrics,3(4),251,1987
35. R.Pasquali, M.P.Cesari, N.Melchionda, S.Boschi, A.Munarini, L.Barbara
Erythrocyte Na/K ATPase membrane activity in obese patients fed over a long term period with a very low calory diet.
Metabolism,37,1,86,1988
S.Boschi, A.Munarini, C.Borghi, E.Strocchi, F.V.Costa, A.Mussi, E.Ambrosioni
Characterization of a Na/K ATPase from human plasma: preliminary data.
Am.J.Hypertension,156S,1988
36. C.Borghi, S.Boschi, F.V.Costa, A.Munarini, A.Mussi, E.Ambrosioni
Inportance of PRA suppression and venous distensibility on pressure and natriuretic responses to intravenous salt load in borderline hypertension.
Am.J.Hypertension,1,294,1988
37. C.Borghi, F.V.Costa, S.Boschi, E.Ambrosioni
Impaired vasodilator capacity and exaggerated pressor response to isometric exercise in subjects with family hystory of hypertension.
Am.J.Hypertension,1,106S,1988
38. C.Borghi, S.Boschi, A.Munarini, F.V.Costa, E.Ambrosioni
Acute venodilation and pressor and humoral response to volume expansion by saline in borderline hypertension.
Am.J.Hypertension,1,63A,1988
39. F.V.Costa, C.Borghi, S.Boschi, A.Mussi,E.Ambrosioni
Long term hemodynamic and humoral effects of antihypertensive treatment with fenquizone: importance of aldosterone response.
J.Clin.Pharmacol.,28,913,1988
40. C.Borghi, F.V.Costa, S.Boschi, E.Ambrosioni
Control of vasodilating activity of fenquizone by aldosterone.
J.Clin.Pharmacol.,28,914,1988
41. E.Ambrosioni, C.Borghi, S.Boschi, F.V.Costa, A.Mussi
Cellular ionic composition at the prehypertensive phase of essential hypertension.
J.Cardiovasc.Pharmacol.,12(supp.3),S85,1988
42. A.Capucci, L.Frabetti, S.Gubelli, G.Boriani, B.Marchesini, S.Boschi, E.Ambrosioni, B.Magnani
Tocainide and metoprolol: an efficacious therapeutic combination in the treatment of premature ventricular beats.
Clin.Cardiol.,12,332,1989
43. M.G.Marlettini, A.Cassani, S.Boschi, A.M.Morselli Labate, S.Crippa, C.Borghi, A.Contarini, A.G.Rusticali, C.Orlandi
Plasma concentration of atrial natriuretic factor in normal pregnancy and early puerperium.
Clin.Exp.Hypertension,A11(4),531,1989
44. C.Borghi, S.Boschi, F.V.Costa, E.Ambrosioni
Effects of angiotensin converting enzyme inhibition on the pressor and humoral response to acute volume expansion in human hypertension.
"Current advances in ACE inhibition", P.Sever & G.A.McGregor Eds,231,Churchill Livingstone, 1989
45. C.Borghi, C.Magelli, S.Boschi, F.V.Costa, M.Capelli, E.Varani, B.Magnani, E.Ambrosioni
Peripheral hemodynamic and humoral effects of oral Zofenopril Calcium (SQ 26,991) in patients with congestive heart failure.
J.Clin.Pharm.,29(12),1077,1989
46. C.Borghi, S.Boschi, F.V.Costa, E.Ambrosioni
Changes in peripheral venous distensibility and blood pressure modifications in borderline hypertension:evidence against a primary role for the renin-angiotensin-aldosterone system.
J.Hypertension,7(S6),S80,1989
47. M.G.Marlettini, A.Cassani, C.Borghi, S.Boschi, A.M. Morselli Labate, S.Crippa, A.Contarini, E.Ambrosioni, C.Orlandi
Fattore natriuretico atriale ed alteraziooni emodinamiche nella malattia ipertensiva della gravidanza.
Gestosi '89,77, CIC Ed.Internazionali,1989
48. C.Borghi, S.Boschi, A.Munarini, F.V.Costa, E.Ambrosioni
Short term PRA suppression by saline and release of a plasma endogenous Na/K ATPase inhibitor in essential hypertension.
Am.J.Hypertension,3,98,1990
49. F.V.Costa, C.Borghi, S.Boschi, A.Mussi, E.Ambrosioni
Hemodynamic and humoral effects of chronic antihypertensive treatment with fenquizone: importance of aldosterone response.
J.Clin.Pharm.,30(3),254,1990
50. N.Galiè, E.Varani, L.Maiello, G.Boriani, S.Boschi, G.Binetti, B.Magnani
Usefulness of nicorandil in congestive heart failure.
Am.J.Cardiol.,65,343,1990
51. C.Borghi, S.Boschi, F.V.Costa, A.Mussi, E.Ambrosioni
Influence of acute venodilation by captopril on the ANP and pressor modifications in borderline hypertension.
in "Advances in atrial peptide research", Brenner B.M. & Laragh J.H. eds., Raven Press
52. G.Boriani, E.Strocchi, A.Capucci, S.Boschi, B.Marchesini, E.Ambrosioni, B.Magnani
Relationships between debrisoquine hydroxylation and propafenone pharmacokinetics.
Drug Invest.,2(2),114,1990
53. F.V.Costa, C.Borghi, S.Boschi, A.Mussi, E.Ambrosioni
Alarm reaction and serum K+ in hypertensive patients.
Am.J.Hypertension,3,638,1990
54. C.Borghi, S.Boschi, F.V.Costa, E.Ambrosioni
Pattern of peripheral venous response to volume expansion in borderline systemic hypertension.
Am.J.Cardiol.,66(5),597,1990
55 S.Boschi, C.Borghi, A.Munarini, F.V.Costa, LuZhuoren, D.deVries, E.Ambrosioni
Purification of Na/K ATPase inhibitor from borderline hypertensives' plasma.
Biochem. Biophys. Res. Comm.,169(2),360,1990
56. C.Borghi, S.Boschi, F.V.Costa, E.Ambrosioni
ANF modulates the plasma levels of Na/K ATPase inhibitor in volume expanded borderline hypertensives
Am.J.Hypertension,3(5,2),83A,1990
57. C.Borghi, S.Boschi, F.V.Costa, E.Ambrosioni
Changes in venous distensibility and release of Na/K ATPase inhibitor in borderline hypertensives
Am.J.Hypertension,3(5,2),83A,1990
58. A.Gentili, V.Bachiocco, G.Grillone, L.Bortoluzzi, S.Boschi, A.Morselli
Modificazioni delle beta-endorfine immunoreattive plasmatiche durante e dopo intervento di chirurgia pediatrica:correlazioni con le scale CHEOPS e FACE-HAPPY- SAD.
Minerva Anestesiologica,56(10),1143,1990
59. F.Verlicchi, S.Boschi, G.Visani, A.Guidi, P.Tosi, S.Tura
Evidence for increased intracellular transport of m- sarcolysine (alkylating moiety) when combined with two aminoacid analogs (PTT-119).
Blut,61,311,1990
60. C.Borghi, G.Melandri, S.Boschi, G.Botta, A.Branzi, B.Magnani, E.Ambrosioni
Effects of oral angiotensin converting enzyme inhibition by Zofenopril in patients with acute myocardial infarction.
J.Clin.Pharm.,30(9),851,1990
61. G.Boriani, E.Strocchi, A.Capucci, S.Boschi, L.Frabetti, E.Ambrosioni, B.Magnani
Determinazione del fenotipo ossidativo in un campione di popolazione e correlazioni con la farmacocinetica del propafenone.
Cardiologia,35(2),163,1990
62. S.Boschi, C.Borghi, F.V.Costa, E.Ambrosioni
Effects of I.V. fructose infusion on plasma levels of endogenous Na/K ATPase inhibitor in pre-hypertensive subjects.
Am.J.Hypertens.,4,5(2),44A,1991
63. C.Borghi, S.Boschi, F.V.Costa, R.De Iasio, E.Ambrosioni
Relative importance of volume expansion and enhanced sodium reabsorption in pressor and vascular changes observedin borderline hypertensive patients.
Am.J.Hypertens.,4,5(2),44A,1991
64. C.Borghi, S.Boschi, F.V.Costa, E.Ambrosioni
Determinants of acute salt sensitivity in hypertensive prone man.
J.Hypertens.,9,(S6),S318,1991
65. C.Borghi, S.Boschi, F.V.Costa, E.Ambrosioni
Atrial Natriuretic Factor modulates the plasma levels of Na/K ATPase inhibitor in volume expanded borderline hypertensives.
Am.J.Hypertens.,4,618,1991
66. E.Ambrosioni, C.Borghi, B.Magnani e SMILE Pilot Study Working Party
Early treatment of acute miocardial infarction with angiotensin converting enzyme inhibition: Safety consideration.
Am.J.Cardiol.,68,101D,1991
67. M.G.Marlettini, C.Borghi, A.M.Morselli Labate, S.Boschi, A.Cassani, S.Crippa, C.Ricci, A.Contarini, E.Ambrosioni, C.Orlandi
Plasma concentrations of atrial natriuretic factor and hemodynamics in pregnancy induced hypertension.
Clin.Exp.Hypertens., A13(8),1305,1991
68. R.Pasquali, S.Cantobelli, F.Casimirri, L.Bortoluzzi, S.Boschi, M.Capelli, N.Melchionda, L.Barbara
The role of opiod peptides in the development of hyperinsulinemia in obese woman with abdominal body fat distribution.
Metabolism,41(7),763,1992
69. C.Borghi, S.Boschi, F.V.Costa, E.Ambrosioni
Factors associated with acute salt sensitivity in borderline hypertensive patients.
Clin.Exp.Hypertens.,A14(5),837,1992
70. C.Borghi, S.Boschi, F.V.Costa, D.Degli Esposti, S.Bacchelli, E.Ambrosioni
Comparison between individual response to acute and chronic sodium loading in borderline hypertensive patients.
Am.J.Hypertens.,5(5),48A,1992
71. C.Borghi, S.Boschi, F.V.Costa, D.Degli Esposti, S.Bacchelli, E.Ambrosioni
Enhanced natriuretic response to NaCl loading after ACE inhibition in borderline hypertensives with blunted renin suppression.
Am.J.Hypertens.,5(5),56A,1992
72. C.Borghi, S.Boschi, F.V.Costa, D.Degli Esposti, S.Bacchelli, E.Ambrosioni
Functional origin and role of impaired atrial natriuretic factor release in hypertensive prone man.
Am.J.Hypertens.,5(5),63A,1992
73. L.Bastagli,M.Degiovanni, G.Vallar, R.DeIasio, S.Boschi, P.Puddu
Variazioni dei livelli plasmatici di NPY nell'infarto miocardico acuto.
Cardiologia,37(11),803,1992
74. L.Bastagli, M.Degiovanni, G.Vallar, L.Zambrini, G.Pepe, R.DeIasio, S.Boschi, P.Puddu
Neuropeptide Y e scompenso cardiaco.
Cardiologia,37(11),813,1992
75. C.Borghi, S.Boschi, F.V.Costa, S.Bacchelli, D.Degli Esposti, E.Ambrosioni
Effects of different dosages of hydrochlorotiazide on blood pressure and the renin-angiotensin-aldosterone system in mild to moderate essential hypertension.
Curr.Ther.Res.,51,6,859,1992
76. L.Checchi, L.Montebugnoli, C.D'Achille, S.Boschi, S.Conti
Clinical significance of holes in gloves for dental use: a spectrophotometric analysis.
Quintessence Int.,23,8,599,1992
77. E.Ambrosioni,C.Borghi, S.Boschi, A.Mussi, F.V..Costa
Factors enhancing the individual sensitivity to sodium in young patients with borderline hypertension.
Ital.J.Mineral Electrolyte Metab.,6,217,1992
78. Lu Zhuoren, S.Boschi, C.Borghi, A.Munarini
Biological properties of partially purified endogenous sodium pump inhibitor from human plasma.
Acta Universitatis Medicinalis Secondae Shanghai,12,42,1992
79. C.Borghi, S.Boschi, G.Melandri, S.Bacchelli, D.DegliEsposti, E.Ambrosioni, B.Magnani
Circulating RAA system and hypotensive response to increasing dose of ACE-inhibitors in patients with myocardial infarction.
JACC,21,2,302,1993
80. C.Borghi, S.Boschi, E.Ambrosioni, G.Melandri, A.Branzi, B.Magnani
Evidence of a partial escape of renin angiotensin aldosterone blockade in patients with a acute myocardial infarction treated with ACE inhibitors.
J.Clin.Pharm.,33,40,1993
81. S.Boschi, R. De Iasio
Separazione di steroidi con colonna Ultracarb
Tecniche Cromatografiche,6(10),9,1993
82. C.Borghi, S.Boschi, F.V.Costa, E.Ambrosioni
Atrial Natriuretic Factor response to acute volume expansion in borderline hypertension. Role of ACE-Inhibition and changes in peripheral venous tone.
Clin.Exp.Hypertens.,15(2),339,1993
83. G.Melandri,F.Semprini, V.Cervi, N.Candiotti, S.Boschi, A.Branzi, B.Magnani
The inactivation of fluid-phase and clot-bound thrombin by low molecular weight dermatane sulphate and heparin is better related with the Heptest than with the APTT.
Thromb.Haemostas.,69(6)891,1993
84. L.Pironi, A.Belluzzi, P.Gionchetti, E.Ruggeri, S.Boschi, C.Guarnieri, U.Caliceti, V.Cenacchi, L.Barbara, M.Miglioli
Possible role of structural lipids in artificial nutrition: comparison of linoleic acid-based with an oleic acid-based enteral formula in humans.
Clinical Nutrition,12,S1,S91,1993
85. D.Vaira, M.Miglioli, M.Menegatti, J.Holton, G.Biasco, P.Mulè, S.Boschi, G.Bisceglia, M.Lombardi, M.Vergura, P.Azzarone, R.LeRose, R.Conte, L.Barbara
Endoscopic findings in 296 asymptomatic blood donors according to high levels of IgG to Helicobacter pylori (HP)
Acta Gastroenterol. Belg.,56,48,1993
86. M.Menegatti, D.Vaira, P.Mulè, J.Holton, S.Boschi, M.Vergura, R.LeRose, C.Serra, M.Miglioli, L.Barbara
Usefulness of a commercial enzyme-linked immunoassay for diagnosis of Helicobacter pylori (HP) infection in clinical practice.
Acta Gastroenterol. Belg.,56,80,1993
87. P.Mulè, D.Vaira, G.Rossi, M.Menegatti, G.Bisceglia, S.Boschi, M.Lombardi, C.Serra, M.Miglioli, L.Barbara
Clinical value of commercial ELISA assay in the diagnosis of helicobacter pylori (HP) infection in a dyspeptic population
Acta Gastroenterol. Belg.,56,81,1993
88. A. Branzi, G.Melandri, F.Semprini, V.Cervi, A.M.Traini, N.Candiotti, S.Boschi
Stable and unstable angina pectoris.
Platelets 1993 International Meeting
Platelets,4,S1,23,1993
89. C.Borghi, S.Boschi, F.V.Costa, S.Bacchelli, D.Degli Esposti, M.Piccoli, E.Ambrosioni
Effects of pharmacological modulation of the renin angiotensin aldosterone system on salt sensitivity in patients with borderline hypertension..
J.Hypertension,11(S5),S248,1993
90. A.Belluzzi, M.Campieri, P.Gionchetti, C.Brignola, F.Rizzello, S.Boschi, M.Miglioli, L.Barbara,
Eicosanoidi e malattie infiammatorie croniche dell'intestino. Possibili modulazioni terapeutiche.
Argomenti di Gastroenterologia Clinica, 6,223,1993
91. C.Borghi, A.Mussi, S.Boschi, F.V.Costa, E.Ambrosioni
Relationship between acute suppression of plasma renin activity and lymphocyte Na+:H+ exchange rate in young patients with borderline hypertension
Am.J.Med.Sci.,30(S1),S159,1994
92. A.Belluzzi, C.Brignola, M.Campieri, P.Gionchetti, F.Rizzello, S.Boschi, S.Cunanne, M.Miglioli, L.Barbara
Zinc sulphate supplementation corrects abnormal erythrocyte membrane long chain fatty acid composition in patients with Crohn's disease.
Aliment.Pharmacol.Ther.,8(1),127,1994
93. F.Canestrari, F.Galli, S.Boschi, M.C.Albertini, G.Gheller, S.De Crescentini, M.Bossù
Erythrocyte Na+,K+-ATPase properties and adenylate energy charge in normotensive and in essential hypertensives.
Clin.Chim.Acta,224,167,1994
94. F.Fontana, P.Bernardi, E.Merlo Pich, S.Boschi, R.De Iasio, M.Capelli, L.Carboni, S.Spampinato
Endogenous opioid system and atrial natriuretic factor in normotensive offspring of hypertensive parents at rest and during exercise test.
J.Hypertens.12,1285,1994
95. P.Gionchetti, M.Campieri, A.Belluzzi, S.Boschi, C.Brignola, M.Miglioli, L.Barbara
Bioavailability of single and multiple doses of a new oral formulation of 5-ASA in patients with inflammatory bowel disease and healthy volunteers.
Aliment. Pharmacol.Ther., 8,535,1994
96. L.Bastagli, G.Pepe, G.Vallar, R. De Iasio, S.Boschi, V.Tomassetti, P.Puddu
Variazioni plasmatiche di neuropeptide Y e catecolamine nell'insufficienza cardiaca acuta e cronica
Cardiologia,39,12(2)11,1994
97. L.Checchi, L.Montebugnoli, S.Boschi, C.D'Achille
Influence of dental glove type on the penetration of liquid through experimental perforation: a spectrophotometric analysis.
Quintessence Int.,25,9,647,1994
98. A.Belluzzi, C.Brignola, M.Campieri, P.Gionchetti, F.Rizzello, C.Belloli, G.DeSimone, S.Boschi, M.Miglioli, L.Barbara
Effects of a new fish oil derivative on fatty acid phospholipid membrane pattern in a group of Crohn's disease patients.
Dig.Dis.Sci, 39(12),2589,1994
99. S.Boschi, R.De Iasio, P.Mesini, G.F.Bolelli, R.Sciajno, R.Pasquali, M.Capelli
Measurement of steroid hormones in plasma by isocratic high performance liquid chromatography coupled to radioimmunoassay.
Clin.Chim.Acta,231,107,1994
100. C.Borghi, S.Boschi, F.V.Costa, S.Bacchelli, D.Degli Esposti, M.Piccoli, M.Capelli, E.Ambrosioni
Effects of intravenous fructose infusion on sodium handling and peripheral vascular tone in pre-hypertensive subjects.
Hypertens.Res.,17,239,1994
101. R.Pasquali, F.Casimirri, R.De Iasio, P.Mesini, S.Boschi, R.Chierici, R.Flamia, M.Biscotti, V.Vicennati
Insulin regulates testosterone and sex hormone binding globulin concentration in adult normal weight and obese man.
J.Clin.Endocrinol.Metab.,80(2),654,1995
102. F.Fontana, P.Bernardi, D.Mirri, G.Iuculano, A.Menchetti, S.Boschi, R.DeIasio, M.Capelli
Plasma atrial natriuretic factor levels, impaired myocardial contractility and pain intensity in uncomplicated acute myocardial infarction.
Pain, 62,213,1995
103. C.Borghi, D. Degli Esposti, A. Cassani, S. Bacchelli, V.Immordino, S.Boschi, C.Orlandi, E.Ambrosioni
Funzione ventricolare sinistra e profilo bioumorale nelle pazienti con ipertensione indotta da gravidanza.
Gestosi '95 a cura di P.Martinelli, U.Montemagno, C.Nappi, A.Paladini, pag71,1995
104. R.Pasquali, S.Cantobelli, V.Vicennati, F.Casimirri, G.Spinucci, R.De Iasio, P.Mesini, S.Boschi, J. Nestler
Nitrendipine treatment in women with polycystic ovary syndrome: evidence for a lack of effects of calcium-channel blockers on insulin, androgens ans sex hormone-binding globulin.
J.Clin.Endocrinol.Metab.,80 (11), 3346, 1995
105. C.Borghi, S.Boschi, F.V.Costa, S.Bacchelli, D.Degli Esposti, V.Immordino, M.Piccoli, E.Ambrosioni
Low dose of ACE inhibitors enhances sodium excretion in volume expanded patients with borderline hypertension
Blood Pressure, 5, 105, 1996
106. A.Belluzzi, C. Brignola, M. Campieri, A. Pera, S.Boschi, M. Miglioli
Effect of an enteric coated fish oil preparation on relapses in Crohn’s disease
N. Eng.J.Med.,334,24,1557,1996
107. C.Borghi, F.V.Costa, S.Boschi , S.Bacchelli, D.Degli Esposti, M.Piccoli, E.Ambrosioni
Factors associated with development of stable hypertension in young borderline hypertensives.
J.Hypertension,14,509,1996
108. A.Belluzzi, S.Boschi, C.Brignola
Enteric coated fish-oil in Crohn’s disease (reply letter)
N.Eng.J.Med.,335,18,1398,1996
109. F.Fontana, P.Bernardi, S.Spampinato, S.Boschi, R.De Iasio, G.Grossi
Pressor effects of endogenous opioid system during acute episodes of blood pressure increases in hypertensive patients.
Hypertension, 29,105, 1997
110. F.Fontana, P.Bernardi, E.Merlo Pich, S.Boschi, R.De Iasio, S.Spampinato, G.Grossi
Opioid peptide modulation in circulatory and endocrine response to mental stress in humans.
Peptides, 18(2), 169, 1997
111. R.Pasquali, C.Macor, V.Vicennati, V.Novo, R.DeIasio, P.Mesini, S.Boschi, R.Vettor
Effects of acute hyperinsulinemia on testosterone serum concentrations in adult obese and normal weight men.
Metabolism, 46,5,526, 1997
112. P.Pirazzoli, E.Cacciari, R.DeIasio, M.C. Pittalis, P. Dallacasa, S.Zucchini, S.Gualandi, S.Salardi, C.David, S.Boschi
Developmental pattern of fetal growth hormone, insulin-like growth factor I, growth hormone binding protein and insulin-like growth factor binding protein -3.
Arch. Dis Childhood, 77,2,F100,1997
113. P.Gionchetti, A Venuri, F.Rizzello, C.Corbelli, S.Fanti, M.Ferretti, S.Boschi, M.Miglioli, M.Campieri.
Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis
Alimentary Pharmacol Ther.,11,679-684,1997
114. F.Fontana, G.Tarsi, S.Boschi, R.De Iasio, N.Monetti, R.Bugiardini
Relationship between plasma endothelin-1 levels and myocardial ischemia induced by exercise testing.
Am.J.Cardiol., 79(7),957-9,1997
115. S.Boschi
Utilità e problematiche del monitoraggio neuroumorale nella patologia cardiovascolare
La Cardiologia nella Pratica Clinica, 4(4), 227-40, 1997
116.A.Cassio, E.Cacciari, A.Balsamo, C.Colli, A.Pasini, GP.Salvioli, M.Lanari, R.De Iasio, S.Boschi, P.Pirazzoli
Low growth hormone-binding protein in infants with congenital hypothyroidism.
J.Clin.Endocrinol.Metab.,83(10),3643-6,1998
117.F.Fontana, P.Bernardi, E.Merlo Pich, S.Boschi, R.DeIasio, S.Spampinato.
Endogenous opioid peptides and mental stress in congetive heart failure patients
Peptides, 19,1,21,1998
118.D.Degli Esposti, C.Borghi, A.Cassani, S.Crippa, V.Immordino, S.Bacchelli, C.Bentivegna S.Boschi, L.Bovicelli, E.Ambrosioni
Alterazioni strutturali e funzione del ventricolo sinistro nella gravidanza complicata da preeclampsia.
GESTOSI '98, pag.129,1998
119.F.Fontana, P.Bernardi, E.Merlo Pich, L.Tartuferi, S.Boschi, R.DeIasio, S.Spampinato.
Opioid peptides in response to mental stress in asymptomatic dilated cardiomyopathy
Peptides, 19,7,1147,1998
120 D.Degli Esposti, C.Borghi, V.Immordino, S.Bacchelli, A.Cassani, S.Boschi, M.Veronesi, L.Bovicelli, E.Ambrosioni
Profilo emodinamico e neuroumorale in diverse condizioni di gravidanza complicata da ipertensione.
GESTOSI ’99,pag.86,1999
121 A.Belluzzi, S.Boschi, C.Brignola, A.Munarini, G.Cariani, F.Miglio
Polyunsaturated fatty acids and inflammatory bowel disease.
Am-J-Clin-Nutr., 71(1 Suppl), 339S-42S, 2000
122. S.Boschi, A.Munarini, F.Franceschetti, P.Mimmi, GF Bolelli, M.Capelli
Esattezza degli immunodosaggi di testosterone, estradiolo, e cortisolo: confronto con gas cromatografia- spettrometria di massa nel programma di controllo della Regione Emilia-Romagna
Ligand Assay, 5(2) , 124, 2000
123. C.Borghi, D. Degli Esposti, V.Immordino, A.Cassani, S.Boschi, L Bovicelli, E.Ambrosioni.
Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia.
Am J Obstet Gynecol.,183(1):140,2000.
124. F.Fontana, P.Bernardi, L.Tartuferi, S.Boschi, R.DeIasio, E.Merlo Pich
Mechanisms of hypertension in patients with chronic obstructive pulmonary disease during acute respiratory failure.
Am.J Med., 109(8),621, 2000
125. F.Fontana, P.Bernardi, E.Merlo Pich, L.Tartuferi, S.Boschi, S.Spampinato
Opioid peptide modulation of circulatory response to hyperventilation in humans
Peptides, 21,1223,2000
126. M.Filicori, G.E. Cognigni, D.Spettoli, W.Ciampaglia, C.Tabarelli de Fatis, P.Pocognoli, B.Cantelli, S.Boschi
Luteinizing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation.
J.Clin.Endocrinol.Metab.,86(1),337,2001
127. F.Fontana, P.Bernardi, L.Tartuferi, S.Boschi, R.DiToro, S.Spampinato
Opioid peptides attenuate blood pressure increase in acute respiratory failure.
Peptides. 22(4):631-7, 2001
128. Migliori M, Tomassetti P, Campana D, Boschi S, Pezzilli R, Piscitelli L, Corinaldesi R, Gullo L.
A meal stimulation test in the diagnosis of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.
Endocrine Apr;17(3):229-32,2002
129. Nanni C, Castellucci P, Farsad M, Pinto C, Moretti A, Pettinato C, Marengo M, Boschi S, Franchi R, Martoni A, Monetti N, Fanti S.
Role of (18)F-FDG PET for Evaluating Malignant Pleural Mesothelioma.
Cancer Biother Radiopharm. Apr;19(2):149-54, 2004
130. Castellucci P, Zinzani P, Nanni C, Farsad M, Moretti A, Alinari L, Battista G, Pettinato C, Marengo M, Boschi S, Canini R, Baccarani M, Monetti N, Fanti S.
(18)F-FDG PET Early After Radiotherapy in Lymphoma Patients.
Cancer Biother Radiopharm. Oct;19(5):606-12, 2004.
131. Alinari L, Zinzani P, Stefoni V, Battista G, Valentini D, Pettinato C, Marengo M, Boschi S, Canini R, Baccarani M, Monetti N, Franchi R, Rampin L, Fanti S, Rubello D.
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation.
Nucl Med Commun. Aug;26(8):689-94,2005
132. Farsad M, Ambrosini V, Nanni C, Castellucci P, Boschi S, Rubello D, Fabbri M, Franchi R, Fanti S.
Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings. Nucl Med Commun. 2005 Sep;26(9):827-30.
133. Farsad M, Schiavina R, Castellucci P, Nanni C, Corti B, Martorana G, Canini R, Grigioni W, Boschi S, Marengo M, Pettinato C, Salizzoni E, Monetti N, Franchi R, Fanti S,
Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis.
J Nucl Med. 2005 Oct;46(10):1642-9
134. Rubello D, Fanti S, Nanni C, Farsad M, Castellucci P, Boschi S, Franchi R, Mariani G, Fig LM, Gross MD
11C-Methionine PET/CT in 99mTc-Sestamibi-negative hyperparathyroidism in patients with renal failure on chronic hemodialysis
Eur J Nucl Med Mol Imaging. 2006 Jan 25;1-7
135. Pantaleo MA, Fanti S, Lollini PL, Boschi S, Biasco G
PET detection of epidermal growth factor receptor in colorectal cancer: a real predictor of response to cetuximab treatment?
Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1510-1.
136. Lodi F, Trespidi S, Di Pierro D, Marengo M, Farsad M, Fanti S, Franchi R, Boschi S.
A simple Tracerlab module modification for automated on-column [11C]methylation and [11C]carboxylation.
Appl Radiat Isot. 2007 Jun;65(6):691-5.
137. Marengo M, Lodi F, Magi S, Cicoria G, Pancaldi D, Boschi S
Assesment of radionuclidic impurities in 2-[18F]Fluoro-2-deoxy-D-glucose ([18F]FDG) routine production
Appl Radiat Isot. 2008, 66(3):295-302.
138. Pantaleo MA, Nannini M, Maleddu A, Fanti S, Ambrosini V, Nanni C, Boschi S, Biasco G. Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Cancer Treat Rev. 2007 34(2):103-21
139. Di Pierro D, Rizzello A, Cicoria G, Lodi F, Marengo M, Pancaldi D, Trespidi S, Boschi S. Radiolabelling, quality control and radiochemical purity assessment of the Octreotide analogue (68)Ga DOTA NOC.
Appl Radiat Isot. 2007 66(8):1091-6
140. Pantaleo MA, Fanti S, Nannini M, Boschi S, Nanni C, Maleddu A, Rubello D, Biasco G.
What oncologists need and require from nuclear medicine.
Eur J Nucl Med Mol Imaging. 2008 35(10):1761-5
141. Lodi F, Rizzello A, Trespidi S, Di Pierro D, Marengo M, Farsad M, Fanti S, Rubello D, Boschi S.
Reliability and reproducibility of N-[11C]methyl-choline and l-(S-methyl[11C])methionine solid- phase synthesis: a useful and suitable method in clinical practice.
Nucl Med Commun.2008,29(8),736-40
142. Pantaleo MA, Nannini M, Lopci E, Castellucci P, Maleddu A, Lodi F, Nanni C, Allegri V, Astorino M, Brandi G, Di Battista M, Boschi S, Fanti S, Biasco G.
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases.
Int J Oncol. 2008 Sep;33(3):443-52.
143. Fanti S, Nanni C, Castellucci P, Farsad M, Montini GC, Marengo M, Pettinato C, Boschi S, Franchi R.
La PET nello studio dei tumori del sistema nervoso centrale
Neurol Sci., 2008, 27, XXX Congresso SIN supplement
144. F Lodi, A Rizzello, A Carpinelli, D Di Pierro, G Cicoria,V Mesisca, M Marengo, Boschi S Automated Synthesis of [11C]Meta Hydroxyephedrine, a PET Radiopharmaceutical for Studying Sympathetic Innervation in the Heart
Computers in Cardiology 2008;35:341−343
145. Pantaleo MA, Nannini M, Maleddu A, Fanti S, Nanni C, Boschi S, Lodi F, Nicoletti G, Landuzzi L, Lollini PL, Biasco G.
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer.
Ann Oncol. 2009 Feb;20(2):213-26
146. Pantaleo MA, Landuzzi L, Nicoletti G, Nanni C, Boschi S, Piazzi G, Santini D, Di Battista M, Castellucci P, Lodi F, Fanti S, Lollini PL, Biasco G
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model..
Clin Exp Med. 2009 Feb 19.
147. A. Rizzello, D. Di Pierro , F. Lodi, S. Trespidi, G. Cicoria, D. Pancaldi, C. Nanni, M. Marengo and S. Boschi
Synthesis and Quality Control of 68Ga-citrate for Routine Clinical PET
Nucl Med Commun.2009,30,7,542-545
148. G. Magini, M. Farsad, M. Frigerio, C. Serra, A. Colecchia , E. Jovine, M. Vivarelli , V.Feletti, R.Golfieri, C.Patti, S. Fanti, R.Franchi, F. Lodi, S.Boschi, M.Bernardi, F.Trevisani.
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma.
Clin Nucl Med.2009 34,10,659-665
149. Pantaleo MA, Nannini M, Fanti S, Boschi S, Lollini PL, Biasco G.
Molecular Imaging of EGFR: It's Time to Go Beyond Receptor Expression.
J Nucl Med. 2009 Jun, 50(7)1195-6
150. Boschi S, Lodi F, Cicoria G, Raul Ledesma J, Knopp R, Rizzello A, Di Pierro D, Trespidi S, Marengo M.
Development of a modular system for the synthesis of PET [(11)C]labelled radiopharmaceuticals Appl Radiat Isot. 2009,67(10),1869-73
151. G.Cicoria, M.Marengo, D. Pancaldi, D.Di Pierro, A. Rizzello, F. Lodi, S.Fanti, S. Boschi Acceptance test and Quality Control of 68Ge/68Ga
Generators Current Radiopharmaceuticals, 2009, 2, 165-68
152. Maleddu A, Pantaleo MA, Castellucci P, Astorino M, Nanni C, Nannini M, Busato F, Di Battista M, Farsad M, Lodi F, Boschi S, Fanti S, Biasco G.
11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma. Tumori. 2009 May-Jun;95(3):382-4.
153. Pantaleo MA, Mishani E, Nanni C, Landuzzi L, Boschi S, Nicoletti G, Dissoki S, Paterini P, Piccaluga PP, Lodi F, Lollini PL, Fanti S, Biasco G.
Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR
Imaging in Cancer by Small Animal PET. Mol Imaging Biol. 2010 12(6):616-25
154. Zanibellato L, Cicoria G, Pancaldi D, Boschi S, Mostacci D, Marengo M
Experimental monitoring of ozone production in a PET cyclotron facility
Appl Radiat Isot. 2010 68(10):1933-6
155. Fanti S, Nanni C, Lopci E, Castellucci P, Rubello D, Farsad M, Boschi S.
Imaging with (11)Carbon labelled PET tracers.
Nucl Med Commun. 2010 Jul;31(7):613-6.
156. Fuccio C, Castellucci P, Schiavina R, Santi I, Allegri V, Pettinato V, Boschi S, Martorana G, Al-Nahhas A, Rubello D, Fanti S.
Role of (11)C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy.
Ann Nucl Med. 2010 Jul;24(6):485-92.
157. Fuccio C, Castellucci P, , Schiavina R, Santi I, Nanni C, Allegri V, Pettinato V, Boschi S, Martorana G, Al-Nahas A, Rubello D, Fanti S.
Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy.
Ann. Nucl. Med 2010 24(6) 485-92.
158. Nanni C, Errani C, Boriani L, Fantini L, Ambrosini V, Boschi S, Rubello D, Pettinato C, Mercuri M, Gasbarrini A, Fanti S.
68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results.
J Nucl Med. 2010 Dec;51(12):1932-6.
159. Pantaleo MA, Nicoletti G, Nanni C, Gnocchi C, Landuzzi L, Quarta C, Boschi S, Nannini M, Di Battista M, Castellucci P, Fanti S, Lollini PL, Bellan E, Castelli M, Rubello D, Biasco G.Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET.
J Exp Clin Cancer Res. 2010 Dec 30;29:173.
160. Infantino A, Cicoria G, Pancaldi D, Ciarmatori A, Boschi S, Fanti S, Marengo M, Mostacci D. Prediction of (89)Zr production using the Monte Carlo code FLUKA.
Appl Radiat Isot. 2011 Aug;69(8):1134-7.
161. Castellucci P, Fuccio C, Rubello D, Schiavina R, Santi I, Nanni C, Allegri V, Montini GC, Ambrosini V, Boschi S, Martorana G, Marzola MC, Fanti S.
Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?
Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):55-63
162. Zanoni L, Lopci E, Ambrosini V, Boschi S, Fanti S.
Alveolar rhabdomyosarcoma with neuroendocrine differentiation detected by Ga-68 DOTA-NOC PET/CT: a case report.
Clin Nucl Med. 2011 Oct;36(10):915-8.
163. Lodi F, Malizia C, Castellucci P, Cicoria G, Fanti S, Boschi S Synthesis of oncological 11C-radiopharmaceuticals for clinical PET
Nucl Med Biol 2012,39(4):447-60
164. S.Boschi, C.Malizia, F.Lodi
Overview and Perspectives on Automation Strategies in Ga-68 Radiopharmaceutical Preparations Recent Results Cancer Res. 2012;194:17-31.
165. S.Boschi, F.Lodi, C.Malizia, G.Cicoria,M.Marengo
Automation synthesis modules review
Appl. Radiat.Isot., 2013 ;76:38-45
166. Ceci F, Castellucci P, Mamede M, Schiavina R, Rubello D, Fuccio C, Ambrosini V, Boschi S, Martorana G, Fanti S (11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy.
Eur J Nucl Med Mol Imaging. 2013 Jan;40(2):149-55
167. Nanni C, Schiavina R, Boschi S, Ambrosini V, Pettinato C, Brunocilla E,Martorana G,Fanti S.
Comparison of (18)F-FACBC and (11)C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results.
Eur J Nucl Med Mol Imaging. 2013 Jul;40 Suppl 1:11-7.
168. Belosi F, Cicoria G, Lodi F, Malizia C, Fanti S, Boschi S, Marengo M.
Generator Breakthrough and Radionuclidic Purification in Automated Synthesis of 68Ga- DOTANOC.
Curr Radiopharm. 2013 Jun 6;6(2):72-7.
169. Lucconi G, Cicoria G, Pancaldi D, Lodi F, Malizia C, Fanti S, Boschi S, Marengo M.
Use of 65Zn as a tracer for the assessment of purification in the 68Ga-DOTANOC synthesis.
Appl Radiat Isot. 2013 May 30;80C:27-31.
170. C. Quarta, F. Lodi, R. Mazza, F.A. Giannone, L. Boschi, C. Nanni, E. Nisoli, S. Boschi, R. Pasquali, S. Fanti, P. Iozzo, U. Pagotto
11C-meta-hydroxyephedrine PET/CT imaging allows in vivo study of adaptive thermogenesis and white-to-brown fat conversion
Molecular Metabolism, 2013, 21;2(3):153-60
171. S. Boschi, F. Lodi, L. Boschi, C. Nanni, S. Chondrogiannis, P.M. Colletti, D.Rubello, S. Fanti
[11C]-meta-hydroxyephedrine: a promising PET radiopharmaceutical for imaging the sympathetic nervous system
Clin Nucl Medicine, 2015, Feb;40(2):e96-e103
172. Martignani C, Diemberger I, Nanni C, Biffi M, Ziacchi M, Boschi S, Corzani A, Fanti S, Sambuceti G, Boriani G.
Cardiac resynchronization therapy and cardiac sympathetic function.
Eur J Clin Invest. 2015 Jun 2. doi: 10.1111/eci.12471. [Epub ahead of print]
173. Nanni C, Schiavina R, Brunocilla E, Boschi S, Borghesi M, Zanoni L, Pettinato C, Martorana G, Fanti S.
18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse: A Comparison to 11C-Choline PET/CT.
Clin Nucl Med. 2015 Aug 40(8) e386-e391.
174. Capitanio S, Nanni C, Marini C, Bonfiglioli R, Martignani C, Dib B, Fuccio C, Boriani G, Picori L, Boschi S, Morbelli S, Fanti S, Sambuceti G
Heterogeneous response of cardiac sympathetic function to cardiac resynchronization therapy in heart failure documented by 11[C]-hydroxy-ephedrine and PET/CT.
Nucl Med Biol. 2015 Nov; 42(11):858-63
175. Boschi S, Lee JT, Beykan S, Slavik R, Wei L, Spick C, Eberlein U, Buck AK, Lodi F, Cicoria G, Czernin J, Lassmann M, Fanti S, Herrmann K.
Synthesis and preclinical evaluation of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand.
Eur J Nucl Med Mol Imaging. 2016 Jun 22. [Epub ahead of print]
176. Iudicello A, Genovese F, Di Iorio V, Cicoria G, Boschi S.
An HPLC and UHPLC-HRMS approach to study PSMA-11 instability in aqueous solution
EJNMMI Radiopharmacy and Chemistry 6:14, 2021
177. Di Iorio V, Boschi S, Sarnelli A, Cuni C, Bianchini D, Monti M, Gorgoni G, Paganelli G, Matteucci F, Masini C.
[18F]F‐PSMA‐1007 Radiolabelling without an On‐Site Cyclotron: A Quality Issue
Pharmaceuticals 2021, 14, 599. https://doi.org/10.3390/ph14070599
178. Boschi S, Todde S.
From radiotracer to radiopharmaceutical: a philosophical approach
Eur. J. Nucl. Med. Mol. Imaging, 2021, 49:3–6 https://doi.org/10.1007/s00259-021-05588-6
179. Boschi S, Todde S
PET radiopharmacy and automation
Nuclear Medicine and Molecular Imaging: Volume 1-4, 2022, pp. 227–234
https://doi.org/10.1016/B978-0-12-822960-6.00004-1
180. Iudicello A, Boschi S, Ghedini P, Lohr F, Panareo S.
Optimization of Precursor Preparation in PSMA-11 Radiolabeling to Obtain a Highly Reproducible Radiochemical Yield
Pharmaceuticals, 2022, 15(3), 343 https://doi.org/10.3390/ph15030343
181.Di Iorio V, Boschi S, Cuni C, Monti M, Severi S, Paganelli G, Masini C.
Production and Quality Control of [177Lu]Lu-PSMA-I&T: Development of an Investigational Medicinal Product Dossier for Clinical Trials
Molecules, 2022, 27, 4143. https://doi.org/10.3390/molecules27134143 [applewebdata://6F18A4FB-ACF2-4421-A190-51E4CC9F3B1A/27,%204143.%20https:/doi.org/10.3390/molecules27134143]
182. Boschi S, Todde S.
Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken'.
Eur. J. Nucl. Med. Mol. Imaging 2023,(50),2921-2924 https://doi.org/10.1007/s00259-023-06244-x
BOOK AND BOOK CHAPTERS
183. S.Todde, A.Bogni, S.Boschi
Produzione e verifiche di qualità dei radiofarmaci estemporanei per PET e terapia. La qualità nella preparazione dei radiofarmaci. Indicazioni per la pratica clinica. G.Lucignani Editor, Springer Verlag 2011
184. F.Lodi, C.Malizia, S.Boschi
Synthesis of [11C] Acetate Radiochemical Syntheses, Radiopharmaceuticals for Positron Emission Tomography: Volume 1 (Wiley Series on Radiochemical Syntheses) Peter J. H. Scott, Brian G. Hockley, Michael R. Kilbourn Editors, Wiley, 2012
185. F.Lodi, A. Carpinelli, C.Malizia, S.Boschi
Synthesis of [11C]-Meta-Hydroxyephedrine ([11C]MHED) Radiochemical Syntheses, Radiopharmaceuticals for Positron Emission Tomography: Volume 1 (Wiley Series on Radiochemical Syntheses). Peter J. H. Scott, Brian G. Hockley, Michael R. Kilbourn Editors, Wiley, 2012
186. A.Duatti, R.M. Moresco, S.Boschi
Sperimentazione preclinica di radiofarmaci
Sperimentazione e Registrazione dei Radiofarmaci. G.Lucignani Editor, Springer Verlag 2013
187. S.Boschi, F.Lodi
Chemistry of PET Radiopharmaceuticals: Labelling Strategies
Basic Science of PET Imaging, M.Khalil Editor,
Springer International Publishing Switzerland, 2017
188. F.Lodi, S.Boschi,
Quality Control of PET radiopharmaceuticals
Basic Science of PET Imaging, M.Khalil Editor,
Springer International Publishing Switzerland, 2017
189. Compendio di Radiochimica e Radiofarmacia. S.Todde, S.Boschi Editors. Edizioni Minerva Medica 2020
190. S.Boschi, F.Lodi
Radiofarmaci marcati con Gallio-68.
Compendio di Radiochimica e Radiofarmacia. S.Todde, S.Boschi Editors. Edizioni Minerva Medica 2020
191 S.Todde, S.Boschi
Radiofarmaci marcati con Fluoro-18
Compendio di Radiochimica e Radiofarmacia. S.Todde, S.Boschi Editors. Edizioni Minerva Medica 2020
